Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors
Abstract
Background
Microwave coagulation therapy (MCT) has become a safe and effective modality with which to treat hepatic tumors; MCT can be applied percutaneously, laparoscopically, thoracoscopically, and during laparotomy. When combined with magnetic resonance (MR) imaging, MCT can be used to treat hepatic tumors located in the subdiaphragmatic area that are difficult to approach by ultrasound, because of the overlaying lower lung field.
Methods
To determine the usefulness of thoracoscopy-assisted interventional MR-MCT (T-IVMR-MCT, n = 73), we compared patients with hepatic tumors that were treated with percutaneous IVMR-MCT (P-IVMR-MCT, n = 69) and with T-IVMR-MCT.
Results
None of patient background, complication and recurrence rate, or length of hospital stay significantly differed between the 2 groups.
Conclusions
IVMR-MCT is a useful modality for treating hepatic tumors. Especially when tumors are located at the hepatic dome, T-IVMR-MCT was minimally invasive, while it appears to improve targeting of peridiagmatic hepatic lesions and has a complication profile similar to P-IVMR-MCT.
Keywords: Hepatic tumor, Microwave coagulation therapy, Real-time magnetic resonance image, Interventional magnetic resonance image
To access this article, please choose from the options below
Supported by a Grant-in-aid No. 20057 from Japan Science and Technology Agency.
PII: S0002-9610(08)00047-0
doi:10.1016/j.amjsurg.2007.08.056
© 2008 Elsevier Inc. All rights reserved.
